New Treatment Options for Hidradenitis Suppurativa

Researchers focusing on the common debilitating skin disease, hidradenitis suppurativa (HS), which causes deep, painful lesions and leads to a poor quality of life have isolated new treatment options after performing a comparative analysis that showed which cells were active – and responsive to medication – in those living with HS. HS is thought to [...]

By |2017-08-18T10:28:39+00:00August 18th, 2017|Dermatology|0 Comments

Concern Over Low Awareness of Contagious Childhood Skin Condition

New survey results show that over half of mums (56 per cent) have never heard of the term ‘water warts’ despite them affecting between five to 11 per cent of children aged 16 years and under. The condition affects a similar number of people as well-known common childhood conditions: impetigo, scabies, and ringworm, but new [...]

By |2017-08-18T10:27:38+00:00August 18th, 2017|Dermatology|0 Comments

New Genetic Mutations Linked to Eczema

A genetic mutation could be the cause of severe eczema, according to new research published in Nature Genetics by researchers at the Uniformed Services University of the Health Sciences (USU). Researchers believe that these new findings could influence new treatment strategies for the millions of individuals who struggle with this chronic condition. Until now, patients with rare genetic [...]

By |2017-06-22T14:04:39+00:00June 23rd, 2017|Dermatology|0 Comments

Rare Skin Disease Informs Treatment of Common Hair Disorders

Researchers from the Perelman School of Medicine at the University of Pennsylvania who study an inherited disorder of skin, hair follicles, nails, sweat glands, and teeth called hypohidrotic ectodermal dysplasia (HED) have identified a mechanism that may also be disrupted in male pattern baldness. They recently published their findings in Nature Communications. About one-in-5,000 to [...]

By |2017-06-22T14:04:42+00:00June 23rd, 2017|Dermatology|0 Comments

New Antibiotic for Acute Bacterial Skin and Skin Structure Infections

A new intravenous antibiotic that could benefit patients and help reduce pressure on hospitals is now available in the UK. Xydalba™ (dalbavancin hydrochloride) is an IV antibiotic approved by the European Medicines Agency (EMA) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults. It is the first and only option [...]

By |2017-06-22T14:04:43+00:00June 23rd, 2017|Dermatology|0 Comments

Innovative Approach Heals Wounds with Cell Therapy

Diabetic patients frequently have lesions on their feet that are very difficult to heal due to poor blood circulation. In cases of serious non-healing infections, a decision to amputate could be made. A new therapeutic approach, presented recently in the Journal of Investigative Dermatology by Canadian researchers affiliated with the University of Montreal Hospital Research [...]

By |2017-06-01T11:52:16+00:00June 1st, 2017|Dermatology|0 Comments

New Hair Growth Mechanism Discovered

In experiments in mice, University of California San Francisco (UCSF) researchers have discovered that regulatory T cells, a type of immune cell generally associated with controlling inflammation, directly trigger stem cells in the skin to promote healthy hair growth. Without these immune cells as partners, the researchers found, the stem cells cannot regenerate hair follicles, leading [...]

By |2017-06-01T11:31:16+00:00June 1st, 2017|Dermatology|0 Comments

Positive Final Appraisal for Psoriatic Arthritis Treatment

Novartis has announced that the National Institute for Health and Care Excellence (NICE) has published a positive Final Appraisal Determination (FAD) recommending the use of Cosentyx (secukinumab) alone or in combination with methotrexate by the NHS in England and Wales to treat adults with active and progressive psoriatic arthritis (PsA) when: The person has peripheral [...]

By |2017-05-11T15:31:59+00:00May 11th, 2017|Dermatology|0 Comments

Laser-Based Dermatological Procedures Revolutionised with New Technique

The first laser treatments used to treat skin conditions, such as benign vascular birthmarks and port-wine stains, were developed more than 40 years ago. Since then, clinicians and dermatologists have seen a rise in demand for minimally invasive laser-based treatments, including tattoo removal. However, it is difficult for the laser light, which is held at [...]

By |2017-05-11T15:21:38+00:00May 11th, 2017|Dermatology|0 Comments

Reasons for Eczema Susceptibility Uncovered

The team at Newcastle University, in collaboration with scientists at Stiefel, a GSK company, have identified how a key skin barrier protein called filaggrin impacts on other proteins and pathways in the skin, which in turn drive the development of eczema. This has also lead them to identify potential targets for future drug development which could treat [...]

By |2017-05-11T15:07:36+00:00May 11th, 2017|Dermatology|0 Comments
Please Choose

Welcome to!
Are you a Qualified Healthcare Professional or Student?

Access to is solely restricted to qualified healthcare professionals and students within the sector.
Powered by Autience